Who owns AstraZeneca?

Key details on AstraZeneca (Ticker: AZN)

Who owns AstraZeneca?

Is AZN a good stock to own? Find out who bought AstraZeneca, who sold AstraZeneca (AZN) stock, and who holds a large position in AstraZeneca.

Fund Name Number of Shares Share Valuation As Of
Wellington Management Company 26.48M $1.97B June 30, 2014
Allianz Asset Management AG 8.70M $564.42M March 31, 2014
SUSQUEHANNA INTERNATIONAL 4.84M $346.02M Sept. 30, 2014
Nomura Holdings 3.91M $279.03M Sept. 30, 2014
Federated Investors 3.84M $249.07M March 31, 2014
Hotchkis and Wiley Capital Management 3.69M $219.03M Dec. 31, 2013
MANAGED ACCOUNT ADVISORS 3.69M $239.20M March 31, 2014
Franklin Resources 3.46M $256.53M June 30, 2014
Mason Capital Management 3.35M $248.63M June 30, 2014
Epoch Investment Partners 3.31M $214.52M March 31, 2014
Scoggin 3.19M $228.11M Sept. 30, 2014
Smithwood Advisers 3.01M $214.75M Sept. 30, 2014
ALLIANCEBERNSTEIN 3.00M $150.17M March 31, 2013
LETKO, BROSSEAU & ASSOCIATES 2.98M $176.71M Dec. 31, 2013
Renaissance Technologies 2.91M $151.31M Sept. 30, 2013
PUTNAM INVESTMENTS 2.76M $196.85M Sept. 30, 2014
FMR 2.73M $195.11M Sept. 30, 2014
Tradewinds Global Investors 2.69M $121.73M June 30, 2012
Robeco Investment Management 2.63M $136.37M Sept. 30, 2013
Hussman Econometrics Advisors 2.52M $112.64M June 30, 2012
Brandes Investment Partners 2.50M $148.65M Dec. 31, 2013
Allianz Global Investors of America 2.45M $113.29M Dec. 31, 2011
UBS AG 2.43M $157.73M March 31, 2014
MORGAN STANLEY 2.36M $175.36M June 30, 2014
GOLDMAN SACHS 2.32M $150.33M March 31, 2014
Schafer Cullen Capital Management 2.30M $164.10M Sept. 30, 2014
BlackRock Advisors 2.16M $128.51M Dec. 31, 2013

Who sold AstraZeneca?

Fund Name Date Sold Number of Shares Sold Share Valuation
Credit Suisse AG March 31, 2013 2.43M $121.89M